Dimensional Fund Advisors’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,336,934
| Closed | -$51.4M | – | 3539 |
|
|
2023
Q2 | $51.4M | Buy |
1,336,934
+52,413
| +4% | +$2.01M | 0.02% | 1344 |
|
|
2023
Q1 | $29.7M | Buy |
1,284,521
+46,441
| +4% | +$1.08M | 0.01% | 1698 |
|
|
2022
Q4 | $32.4K | Buy |
1,238,080
+124,336
| +11% | +$3.26K | 0.01% | 1601 |
|
|
2022
Q3 | $21.9M | Buy |
1,113,744
+281,338
| +34% | +$5.53M | 0.01% | 1774 |
|
|
2022
Q2 | $14.6M | Buy |
832,406
+311,931
| +60% | +$5.46M | 0.01% | 2030 |
|
|
2022
Q1 | $8.52M | Buy |
520,475
+228,640
| +78% | +$3.74M | ﹤0.01% | 2362 |
|
|
2021
Q4 | $4.76M | Buy |
291,835
+86,052
| +42% | +$1.4M | ﹤0.01% | 2576 |
|
|
2021
Q3 | $2.63M | Buy |
205,783
+109,177
| +113% | +$1.39M | ﹤0.01% | 2766 |
|
|
2021
Q2 | $1.36M | Buy |
96,606
+83,302
| +626% | +$1.18M | ﹤0.01% | 2965 |
|
|
2021
Q1 | $207K | Sell |
13,304
-70,394
| -84% | -$1.1M | ﹤0.01% | 3284 |
|
|
2020
Q4 | $1.33M | Sell |
83,698
-76,605
| -48% | -$1.22M | ﹤0.01% | 2914 |
|
|
2020
Q3 | $1.95M | Sell |
160,303
-1,256
| -0.8% | -$15.3K | ﹤0.01% | 2754 |
|
|
2020
Q2 | $1.87M | Buy |
161,559
+9,836
| +6% | +$114K | ﹤0.01% | 2778 |
|
|
2020
Q1 | $2.08M | Buy |
151,723
+21,507
| +17% | +$294K | ﹤0.01% | 2699 |
|
|
2019
Q4 | $768K | Sell |
130,216
-22,564
| -15% | -$133K | ﹤0.01% | 3063 |
|
|
2019
Q3 | $810K | Sell |
152,780
-18,568
| -11% | -$98.4K | ﹤0.01% | 3051 |
|
|
2019
Q2 | $1.32M | Buy |
171,348
+18,503
| +12% | +$142K | ﹤0.01% | 2993 |
|
|
2019
Q1 | $3.04M | Buy |
152,845
+40,713
| +36% | +$810K | ﹤0.01% | 2792 |
|
|
2018
Q4 | $1.48M | Buy |
112,132
+53,274
| +91% | +$703K | ﹤0.01% | 2935 |
|
|
2018
Q3 | $2.16M | Buy |
58,858
+46,455
| +375% | +$1.71M | ﹤0.01% | 2916 |
|
|
2018
Q2 | $434K | Buy |
12,403
+7,317
| +144% | +$256K | ﹤0.01% | 3145 |
|
|
2018
Q1 | $236K | Hold |
5,086
| – | – | ﹤0.01% | 3206 |
|
|
2017
Q4 | $191K | Buy |
+5,086
| New | +$191K | ﹤0.01% | 3228 |
|